1458 related articles for article (PubMed ID: 17564313)
61. The matrix metalloproteinase system in oral squamous cell carcinoma.
Baker EA; Leaper DJ; Hayter JP; Dickenson AJ
Br J Oral Maxillofac Surg; 2006 Dec; 44(6):482-6. PubMed ID: 16338034
[TBL] [Abstract][Full Text] [Related]
62. Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury.
Yang K; Palm J; König J; Seeland U; Rosenkranz S; Feiden W; Rübe C; Rübe CE
Int J Radiat Biol; 2007 Oct; 83(10):665-76. PubMed ID: 17729161
[TBL] [Abstract][Full Text] [Related]
63. Drusen are Cold Spots for Proteolysis: Expression of Matrix Metalloproteinases and Their Tissue Inhibitor Proteins in Age-related Macular Degeneration.
Leu ST; Batni S; Radeke MJ; Johnson LV; Anderson DH; Clegg DO
Exp Eye Res; 2002 Jan; 74(1):141-54. PubMed ID: 11878827
[TBL] [Abstract][Full Text] [Related]
64. Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis.
Hayashi T; Stetler-Stevenson WG; Fleming MV; Fishback N; Koss MN; Liotta LA; Ferrans VJ; Travis WD
Am J Pathol; 1996 Oct; 149(4):1241-56. PubMed ID: 8863673
[TBL] [Abstract][Full Text] [Related]
65. Balance between matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) in the cervical mucus plug estimated by determination of free non-complexed TIMP.
Becher N; Hein M; Uldbjerg N; Danielsen CC
Reprod Biol Endocrinol; 2008 Sep; 6():45. PubMed ID: 18826601
[TBL] [Abstract][Full Text] [Related]
66. Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers.
Curran S; Dundas SR; Buxton J; Leeman MF; Ramsay R; Murray GI
Clin Cancer Res; 2004 Dec; 10(24):8229-34. PubMed ID: 15623598
[TBL] [Abstract][Full Text] [Related]
67. Immunocytochemical detection of MMP-3 and -10 expression in hepatocellular carcinomas.
Bodey B; Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 2000; 20(6B):4585-90. PubMed ID: 11210857
[TBL] [Abstract][Full Text] [Related]
68. Expression of matrix metalloproteinases in the microenvironment of spontaneous and experimental melanoma metastases reflects the requirements for tumor formation.
Hofmann UB; Eggert AA; Blass K; Bröcker EB; Becker JC
Cancer Res; 2003 Dec; 63(23):8221-5. PubMed ID: 14678978
[TBL] [Abstract][Full Text] [Related]
69. Role of matrix metalloproteinases and their tissue inhibitor of metalloproteinases in myxomatous change of cardiac floppy valves.
Togashi M; Tamura K; Nitta T; Ishizaki M; Sugisaki Y; Fukuda Y
Pathol Int; 2007 May; 57(5):251-9. PubMed ID: 17493172
[TBL] [Abstract][Full Text] [Related]
70. Secretion of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases into follicular fluid during follicle development in equine ovaries.
Riley SC; Gibson AH; Leask R; Mauchline DJ; Pedersen HG; Watson ED
Reproduction; 2001 Apr; 121(4):553-60. PubMed ID: 11277874
[TBL] [Abstract][Full Text] [Related]
71. Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage I and II endometrial cancer.
Moser PL; Hefler L; Tempfer C; Neunteufel W; Kieback DG; Gitsch G
Anticancer Res; 1999; 19(3B):2365-7. PubMed ID: 10472357
[TBL] [Abstract][Full Text] [Related]
72. Evaluation of PRL-3 expression, and its correlation with angiogenesis and invasion in hepatocellular carcinoma.
Zhao WB; Li Y; Liu X; Zhang LY; Wang X
Int J Mol Med; 2008 Aug; 22(2):187-92. PubMed ID: 18636172
[TBL] [Abstract][Full Text] [Related]
73. [Study on effect of dexamethasone on the expression of matrix metalloproteinase and its tissue inhibitors in hyperoxia-induced lung injury].
Liu CJ; Xu F; Kuang FW; Dang R; Lu ZY; Wang XY
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Oct; 16(10):618-21. PubMed ID: 15461845
[TBL] [Abstract][Full Text] [Related]
74. Expression of matrix metalloproteinases and their inhibitors in retinoblastoma.
Adithi M; Nalini V; Kandalam M; Krishnakumar S
J Pediatr Hematol Oncol; 2007 Jun; 29(6):399-405. PubMed ID: 17551402
[TBL] [Abstract][Full Text] [Related]
75. Gelatinases and their tissue inhibitors during human ovulation: increased expression of tissue inhibitor of matrix metalloproteinase-1.
Lind AK; Dahm-Kähler P; Weijdegård B; Sundfeldt And K; Brännström M
Mol Hum Reprod; 2006 Dec; 12(12):725-36. PubMed ID: 17071711
[TBL] [Abstract][Full Text] [Related]
76. Expression of matrix metalloproteinases (MMP-2 and -9) and their inhibitors (TIMP-1 and -2) in prostate cancer tissue.
Brehmer B; Biesterfeld S; Jakse G
Prostate Cancer Prostatic Dis; 2003; 6(3):217-22. PubMed ID: 12970724
[TBL] [Abstract][Full Text] [Related]
77. Inhibitory effects of a benz[f]indole-4,9-dione analog on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.
Park HJ; Lee HJ; Min HY; Chung HJ; Suh ME; Park-Choo HY; Kim C; Kim HJ; Seo EK; Lee SK
Eur J Pharmacol; 2005 Dec; 527(1-3):31-6. PubMed ID: 16309669
[TBL] [Abstract][Full Text] [Related]
78. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.
Ahmed SH; Clark LL; Pennington WR; Webb CS; Bonnema DD; Leonardi AH; McClure CD; Spinale FG; Zile MR
Circulation; 2006 May; 113(17):2089-96. PubMed ID: 16636176
[TBL] [Abstract][Full Text] [Related]
79. Purified human chondroitin-4-sulfate reduced MMP/TIMP imbalance induced by iron plus ascorbate in human fibroblast cultures.
Campo GM; Avenoso A; Campo S; D'Ascola A; Ferlazzo AM; Samà D; Calatroni A
Cell Biol Int; 2006 Jan; 30(1):21-30. PubMed ID: 16275145
[TBL] [Abstract][Full Text] [Related]
80. Matrix metalloproteinases, TIMPs and growth factors regulating ameloblastoma behaviour.
Siqueira AS; Carvalho MR; Monteiro AC; Freitas VM; Jaeger RG; Pinheiro JJ
Histopathology; 2010 Jul; 57(1):128-37. PubMed ID: 20653784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]